drugset / Trial / NCT02147808

A Open-Label Drug-Drug Interaction Study of Telotristat Etiprate and Midazolam in Healthy Subjects

NCT02147808

Phase 1 Completed 24 enrolled Lexicon Pharmaceuticals
NaSingle-groupOpen-labelTreatment

Summary

This study is designed to evaluate the effects of telotristat ethyl on the pharmacokinetics of midazolam in healthy male and female subjects.

Timeline

Start
2014-05
Primary completion
2014-08
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Midazolam Small molecule 3 mg Oral
Subject Telotristat etiprate Unknown 500 mg

Indications

No indication recorded.